TGFB1 and scleroderma: Previous studies of a rat bleomycin model of pulmonary fibrosis show that TGF-β1 expression peaks at day 6 and day 21 [19] and that overexpression of TGF-β1 plays an important role in dermal and pulmonary fibrosis in scleroderma patients [20].